This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated NLRP12 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NLRP12 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~120.2 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Fallopian tube (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | — | |
| Caveat | — | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 7 isoform(s) |
The A02124 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human brain tissue lysate (catalog A02124) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A02124 · 1 μg/mL (catalog A02124) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
NLRP12 is predicted at 120.2 kDa; seven isoforms could affect band patterns, but no empirical migration or resolvable isoform sizes are supplied.
| Band near 120.2 kDa | Consistent with the predicted NLRP12 mass; identity requires controls |
| Several bands at different positions | Could reflect expression of multiple NLRP12 splice isoforms |
| Band below 120.2 kDa | Could represent a shorter splice isoform; its mass is unknown |
| Band above 120.2 kDa | Could represent a larger splice isoform; its mass is unknown |
| Predicted NLRP12 mass | Provides a 120.2 kDa reference, not a measured band position |
| Splice isoform 1 | Its individual migration is not supplied |
| Splice isoforms 2, 3, and 4 | May differ in size from other isoforms; relative masses are not supplied |
| Splice isoforms 5, 6, and 7 | May differ in size from other isoforms; relative masses are not supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | NLRP12 may be insufficiently abundant in the sampled lysate | Check loading and use a confirmed NLRP12-positive lysate |
| Band higher than expected | A splice isoform or an unrelated protein could produce the band | Confirm identity by NLRP12 knockdown or a second antibody |
| Band lower than expected | A shorter splice isoform or an unrelated protein could produce the band | Check isoform expression and confirm identity by NLRP12 knockdown |
| Multiple bands | Seven annotated isoforms could contribute, but their migration is unknown | Compare isoform expression and validate candidate bands with NLRP12 knockdown |
| Weak or no signal | Low NLRP12 abundance or insufficient antibody sensitivity | Verify loading and compare with a confirmed NLRP12-positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Fallopian tube | glandular cells | High | Protein (IHC) | HPA → |
| Skeletal muscle | myocytes | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | Medium | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Parathyroid gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Smooth muscle | smooth muscle cells | Not detected | Protein (IHC) | HPA → |
| Urinary bladder | urothelial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for NLRP12, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
the supplier A02124 is an anti-NLRP12 antibody listed for human, mouse, and rat. Its WB image shows NLRP12 analysis in human brain tissue lysate at 1 μg/mL; the supplied caption does not show mouse or rat WB samples.
Which to pick: A02124 is the only listed option. It has a WB image using human brain tissue lysate. For mouse or rat samples, the catalog lists reactivity, but the supplied WB evidence is from human tissue.